Elon Musk said Wednesday that his brain tech startup Neuralink hopes to implant its system in a second human patient within "the next week or so." No BCI company has received approval from the U.S. Food and Drug Administration to commercialize their devices. In a livestream with Neuralink executives Wednesday, Musk said the company is hoping to implant its device in the "high single digits" of patients this year. However, in the weeks following the procedure, Neuralink said some threads from the implant retracted from Arbaugh's brain. Musk and the Neuralink executives said during Wednesday's livestream that only around 15% of the channels in Arbaugh's implant are functional.

---

Persons: Elon Musk, Musk, Neuralink, Noland Arbaugh, Wednesday's, DJ Seo, Matthew MacDougall Organizations: BCI, Neuroscience, U.S . Food, Drug Administration, Barrow Neurological, FDA, Wall Street, CNBC Locations: U.S, Barrow, Phoenix , Arizona, Neuralink